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AbstrACt 
Introduction This study protocol outlines our planned 
systematic review and dose-response meta-analysis of 
postdiagnosis physical activity and mortality in people with 
non-communicable diseases (NCDs).
Methods and analysis This study is based on the 
Preferred Reporting Items for Systematic Reviews and 
Meta-analysis for Protocols. A systematic literature search 
will be conducted in various databases—namely, PubMed, 
Scopus and Web of Science—by two researchers in 
order to identify prospective observational studies that 
investigate postdiagnosis physical activity or activity-
related energy expenditure and mortality in individuals 
with NCDs. The target population is adults (≥18 years 
of age) with one of the following nine NCDs: low back 
pain, type 2 diabetes mellitus, osteoarthritis, depressive 
disorder, chronic obstructive pulmonary disease, breast 
cancer, lung cancer, stroke or ischaemic heart disease. We 
will focus on all-cause mortality as the primary outcome 
and investigate indication-specific mortality as the 
secondary outcome. For each study identified as a result 
of the literature search, we will conduct graphical dose-
response analyses of mortality as a function of activity-
related energy consumption. If more than two studies 
are available for one disease, we will perform linear 
and non-linear dose-response meta-analyses for said 
disease using random-effects models. We will investigate 
the heterogeneity of the studies and publication bias. To 
assess the risk of bias and the quality of the included 
studies, we will use the Risk Of Bias In Non-randomised 
Studies - of Interventions tool, which is a Cochrane tool.
Ethics and dissemination This systematic review will 
be conducted in compliance with ethical precepts. As the 
systematic review is based on published studies, approval 
from an ethics committee is not required. The systematic 
review and meta-analysis will be published in a peer-
reviewed journal.
PrOsPErO registration number CRD42018103357
IntrOduCtIOn
The World Health Organization (WHO) 
recommends at least 150 min of moder-
ate-intensity physical activity or 75 min of 
vigorous-intensity physical activity per week 
to enhance health and reduce mortality.1 For 
additional benefits, adults should increase 
their moderate-intensity physical activity to 
300 min or engage in 150 min of vigorous-in-
tensity physical activity per week. These 
recommendations apply to both healthy 
adults and adults with non-communicable 
diseases (NCDs) (eg, ischaemic heart disease, 
breast cancer, chronic pulmonary disease). 
However, if one considers the scientific 
evidence for physical activity and mortality 
on which the recommendations are based, 
an extensive disparity becomes apparent 
between healthy populations and those with 
a pre-existing NCD.
The data for healthy adults are compre-
hensive and unambiguous. Numerous large 
cohort studies have consistently demon-
strated an inverse relationship between phys-
ical activity and mortality.2 Arem et al.3 pooled 
data from six cohort studies of 661 137 
persons. Compared with individuals who 
strengths and limitations of this study
 ► Our systematic review will be conducted and re-
ported in accordance with the reporting guide-
lines provided in the Preferred Reporting Items for 
Systematic Reviews and Meta-analysis for Protocols 
statement and the reporting guidelines of the Meta-
analysis Of Observational Studies in Epidemiology.
 ► The scope of our systematic search is wide-reach-
ing, as it includes nine non-communicable diseases 
and three extensive medical databases.
 ► The study uses the novel Risk Of Bias In Non-
randomised Studies—of Interventions tool.
 ► However, the observational cohort studies do not 
provide a conclusive answer regarding the causality 
between physical activity and mortality.
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reported having no leisure-time physical activity, prema-
ture death decreased with increased physical activity 
levels: 7.5 metabolic equivalent tasks (MET) hours/week 
(HR=0.80; 95% CI 0.78 to 0.82); 7.5–15 MET hours/week 
(HR=0.69; 0.67 to 0.70); and 15–22.5 MET hours/week 
(HR=0.63; 0.62 to 0.65). These findings are consistent 
with the meta-analysis conducted by Samitz et al.4 This 
analysis comprised 80 studies with a total of 1 338 143 
persons. Compared with the lowest activity group, the 
risk of premature death was remarkably reduced in the 
highest activity group (HR=0.65; 95% CI 0.60 to 0.71). 
Furthermore, each 1 hour increment of moderate-inten-
sity activity per week resulted in a lowered risk ratio (RR) 
of 0.96 (95% CI 0.93 to 0.98).
Accordingly, the updated physical activity guidelines 
from the US Department of Health and Human Services5 
include a clear dose-response relationship between the 
volume of physical activity and the mortality rates of 
healthy adults. The shape of the dose-response curve is 
not linear but regressive, thus meaning that the greatest 
difference in mortality rates occurs among inactive and 
minimally active individuals. It is clear that benefits 
can be gained with any amount of physical activity. For 
healthy individuals, current scientific research is sceptical 
of a minimum dose of physical activity to ensure lifetime 
extension. Following the minimum recommendations, 
physical activity is equivalent to energy expenditure of 
8.25 MET hours/week. At this level of physical activity, 
about 70% of the benefits in relation to mortality rates 
are reached.6 Higher volumes of physical activity mean 
that the dose–response curve flattens out. However, 
roughly five times this dose is also associated with more 
risk reductions and no adverse effects.
For individuals with distinct NCDs, the scientific data 
on the dose-response relationship between physical 
activity and mortality are considerably weaker. For cancer, 
the meta-analysis by Li et al.7 suggests that postdiagnosis 
physical activity levels may result in similar risk reductions 
in mortality. Moore et al.8 pooled data from six cohort 
studies that comprised 654 827 individuals and adjusted 
their analysis for several confounders, including pre-ex-
isting NCDs. In contrast to Li et al.,7 they conclude that 
the longevity effects of physical activity vary according to 
the pre-existing NCD. The current evidence from the US 
Physical Activity Guidelines Advisory Committee6 reports 
a general relationship between higher postdiagnosis phys-
ical activity and lower mortality rates in five NCDs (breast 
cancer, colorectal cancer, prostate cancer, cardiovascular 
condition of hypertension and type 2 diabetes). However, 
this report did not demonstrate the dose-response rela-
tionships due to the limited information it had regarding 
the NCDs that were worked on. In addition, the report 
does not include all NCDs with high levels of morbidity 
and mortality in Western countries. In Germany, the 
following NCDs are in the top 10 NCDs with the highest 
burden of disease: ischaemic heart disease, low back pain, 
lung cancer, breast cancer, stroke, chronic obstructive 
pulmonary disease (COPD), major depressive disorder 
and diabetes.9 The high disease burden of these NCDs 
refers to the loss of life due to premature death and years 
spent living with a disability as a result of the disease. For 
some NCDs, such as low back pain or major depressive 
disorder, the high burden is mainly caused by a loss of 
healthy years. However, the data from Plass et al.9 also 
show at least a small influence on mortality rates. Overall, 
it is unclear whether physical activity positively affects 
mortality rates in individuals with NCDs in the same way 
that physical activity affects the mortality rates of healthy 
individuals. Thus, it is clear that the dose-response rela-
tionship between physical activity and mortality in adults 
with a NCD is not well defined at present.
Objectives
This study protocol aims to describe the planned system-
atic review and dose-response meta-analysis of physical 
activity and mortality in adults with NCDs. The planned 
study aims to define the dose-response relationship 
between postdiagnosis physical activity and mortality rates 
for nine NCDs with a high global burden of disease,10 
especially in Germany.9 The nine NCDs are: low back 
pain, type 2 diabetes mellitus, osteoarthritis, depressive 
disorder, COPD, breast cancer, lung cancer, stroke and 
ischaemic heart disease. Our results may inform updates 
on national physical activity recommendations for indi-
viduals with NCDs.5 6 The planned dose-response analyses 
may help specify the recommended amount of physical 
activity and define a minimum, optimum and maximum 
dose of physical activity for individuals with NCD.
MEthOds
This protocol adheres to the Preferred Reporting Items 
for Systematic Reviews and Meta-analysis for Protocols 
(online supplementary file 1).11 Our systematic review 
will be conducted and reported in accordance with the 
reporting guidelines provided in the Preferred Reporting 
Items for Systematic Reviews and Meta-Analysis statement 
and the Meta-analysis Of Observational Studies in Epide-
miology reporting guidelines.12 13 Additionally, the Meth-
odological Expectations of Cochrane Intervention Reviews and 
the Cochrane Handbook of Systematic Reviews in Interventions 
will be consulted to ensure methodological quality.14 15
In view of the recommendations that endorse the 
preregistration of systematic reviews, our protocol was 
registered with the International Prospective Register 
of Systematic Reviews on 5 September 2018 (available 
online at https://www. crd. york. ac. uk/ prospero/ display_ 
record. php? RecordID= 103357).
Eligibility criteria
This study will only include research published in the 
English language. There are no time restrictions in rela-
tion to the year of publication. We will include studies 
that investigate the association between postdiagnosis 
physical activity levels and mortality among adults with 
NCD and report on the effect estimates, including the 
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HRs, relative risks, ORs or absolute mortality rates.12 16 For 
this study, postdiagnosis physical activity will be defined as 
any form of physical activity, such as leisure-time, occu-
pational, transport-related, exercise and any physical 
activity-related energy expenditure measured after diag-
nosis. Physical activity can be measured using subjective 
methods (eg, questionnaires) or objective methods (eg, 
accelerometry). Physical activity-related energy expendi-
ture can be measured using any kind of objective method 
(eg, doubly labelled water).
Studies will be excluded if they: (1) clearly deal with 
another topic; (2) include only the total population 
without information for subgroups with NCDs at the base-
line; (3) focus on prevention only (ie, when they include 
individuals at risk of developing one of the nine diseases); 
(4) report insufficient data (ie, less than three different 
physical activity levels in MET hours per week) to calcu-
late the dose-response relationship; (5) are duplicate 
studies that are based on a data set that has already been 
taken into account.
Participants
The participants for the study will be comprised of 
those who are ≥18 years of age with at least one of the 
following nine NCDs at the baseline: osteoarthritis, low 
back pain, depressive disorder, ischaemic heart disease, 
type 2 diabetes mellitus, stroke, COPD, lung cancer or 
breast cancer. The disease can either be confirmed by a 
physician or determined by self-reporting. Studies that 
have children, adolescents and pregnant women as the 
participants will be excluded, as will studies that focus on 
animal and cell cultures.
Outcomes
The outcomes will be studies that assessed all-cause 
mortality as the primary endpoint or any indication-spe-
cific mortality as the primary or secondary endpoint.
Study design
Prospective observational studies, including cohort, 
nested case-control, case-cohort studies and follow-up 
studies of randomised controlled studies published in a 
peer-reviewed journal will be included. We will exclude 
cross-sectional, case only or casecontrol studies, confer-
ence abstracts, comments, letters and reviews.
Information sources
Two researchers will search the following electronic data-
bases: MEDLINE (PubMed), Scopus and the Web of 
Science Core Collection (Web of Science). All years will 
be covered. The reference list from the systematic reviews 
and meta-analyses will be manually searched to locate 
further results. Additionally, one researcher will use the 
Google Scholar forward citation search for all eligible 
articles identified via the database search.
search strategy
The search strategy was developed with the support of 
a specialist from the University Library. The search is 
structured according to three main categories of the 
population, intervention, comparison, outcome (PICO) 
concept. The population is people with one of the 
nine NCDs; the intervention is the physical activity; the 
outcome is mortality; and control, as the fourth category 
of PICO, does not play a role in the cohort studies we 
sought out.17 We defined the search terms for the three 
PICO categories; these terms included keywords and 
related synonyms, abbreviations, spelling variations and 
controlled vocabulary, each separated by Boolean oper-
ator OR. The search terms for the three PICO catego-
ries will be combined with Boolean operator AND. The 
search will be restricted to the search fields of the title 
and the abstract. Independent searches will be conducted 
for the nine NCDs under consideration. The search is 
adapted to the special features of the three databases (eg, 
the use of medical subject heading terms in PubMed). It 
should be noted that the search is not filtered for obser-
vational studies, as reference lists of systematic reviews 
and meta-analyses are eligible for additional manual 
searching. The concrete search terms used can be found 
in online supplementary file 2.
data management
The search results will be imported to the reference 
management and knowledge organisation software, 
Citavi V.5. We will use separate project folders for each 
of the nine NCDs. These folders will be organised hierar-
chically in categories, based on the various inclusion and 
exclusion filters.
selection of eligible studies
First, one researcher will screen each article’s title and 
abstract against the eligibility criteria to identify all rele-
vant studies. Then, a second researcher will perform 
the same screening task to ensure that no studies were 
overlooked or incorrectly included. This procedure will 
have a positive effect on the accuracy and reliability of the 
screening process.18 Moreover, increasing the number of 
contributors in this critical point of the systematic review 
enables the improved timeliness and efficiency of the 
process.19 If the screening process of the title and abstract 
does not lead to a clear result, the article will be retrieved 
for full-text screening.
data extraction
Data of the full texts will be independently extracted by 
two reviewers using an Excel table (online supplementary 
file 3). This table has been pilot-tested with a number 
of eligible articles from four reviewers (AR, EM, LM, 
WG). The ensuing discussion secured a mutual under-
standing of the variables, the standardisation of the Excel 
data mask and a uniform system of data extraction. The 
results of the double data extraction will be checked for 
consistency. Any disagreements will be openly discussed 
by the three reviewers. Multiple publications with the 
same or very similar content will only be considered once; 
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duplicates with smaller sample sizes and shorter follow-up 
durations will be excluded.
data items
The information for extraction includes basic details such 
as the name of the first author, year of publication, study 
name, design, country where research was undertaken, 
age and sex of participants and mean follow-up time. Addi-
tionally, we will retrieve data regarding the total sample, 
total all-cause death cases, the number of participants in 
each physical activity category, death cases per the corre-
sponding category, diagnosis and mortality data ascertain-
ment, exposure to physical activity (eg, MET hours/week, 
min/day) and any corresponding categories. Finally, RR 
with 95% CIs will be extracted from fully adjusted models 
for every physical activity exposure category, as well as for 
doseresponse data, when available.
Outcomes
The primary outcome of this review will be all-cause 
mortality, defined as the number of deaths over the entire 
period of follow-up, regardless of the underlying cause 
of death. As previously discussed, overall mortality is one 
of the main investigated types of death attributable to a 
lack of physical activity in persons affected by NCD. The 
relationship between physical activity and longevity is 
complex,20 and during a certain timeframe, death can be 
caused or affected by multiple factors. Hence, disease-spe-
cific standardised death rates can exclude many cases that 
can blur the identification of a possible causal relation. If 
all-cause mortality rates are not reported, disease-specific 
mortality rates will be considered. Thus, the secondary 
outcomes include indication-specific mortalities such as 
breast cancer mortality.
risk of bias assessment
Assessment of bias across the included studies is very 
important, as the results can affect the variability among 
single studies and consequently, the meta-analysis.21 We 
will use the Cochrane Risk Of Bias In Non-randomised 
Studies - of Interventions (ROBINS-I) for assessing bias.22 
This tool pays particular attention to the internal validity 
of a study by comparing it to a hypothetical randomised 
controlled trial (RCT). The external validity of the study is 
not considered in this tool, and any generalisability, appli-
cability or ethical issues will not affect our judgement.
ROBINS-I is a domain-based method of assessing 
the risk of bias. Seven domains are included in total. 
Confounding factors and selection bias have always been a 
matter of importance in observational study designs, and 
both of these elements constitute two essential domains 
of ROBINS-I.23 The additional domains of ROBINS-I 
include the classification of interventions, deviations 
from intended interventions, missing data, measure-
ment of outcomes and selection of the reported results.24 
Through ROBINS-I, systematic appraisal is conducted in 
three phases.
Phase I
The protocol stage focuses on any general forethoughts 
to be considered prior to appraising each study. This 
stage specifies the review question, identifies the relevant 
confounding domains for the included studies and notes 
possible cointerventions (exposures) that have an impact 
on study outcomes.
Phase II
The second stage is concerned with hypothesising a RCT 
and elaborating on the confounders and cointerventions 
for each study.
Phase III
The final stage focuses on the actual appraisal in the seven 
domains that expose the study to the risk of bias. This 
instrument contains five options to answer the signalling 
questions—namely, yes, probably yes, no, probably not 
and no information. In the same manner, the domain-spe-
cific judgments are based on five categories—namely, low, 
moderate, serious, critical risk and no information.
Each study will be independently rated by two reviewers, 
and any disagreement will be first noted and then 
followed by a discussion and consultation with a third 
group member. The final assessment will result in a table 
that includes all of the studies along with the domain-spe-
cific and overall conclusions reached by the reviewers.
Meta-biases assessment
We are aware of the implication of meta-biases (eg, 
sampling, selection and data extraction bias) for the 
internal validity of this study.25 To minimise meta-bi-
ases, the entire process will follow the suggestions of the 
above guidelines. Retrieval bias will be minimised with a 
comprehensive and representative search strategy. If the 
number of included studies permits this, publication bias 
will be assessed via funnel plots.26 To minimise selection 
bias, inclusion criteria were selected on the basis of a 
comprehensive discussion. Furthermore, we will employ 
a double-check screening method against a clearly 
defined and specific criterion for eligibility. To address 
extractor biases, we will use a double-check approach of 
data extraction, which has been proven to improve the 
extraction process.27 28 This review is limited to peer-re-
viewed published literature. A supplementary search for 
unpublished studies and literature will not occur, thus 
meaning that, to a certain extent, this review is suscep-
tible to grey literature bias.29
synthesis of results
First, following the methodological approach of 
Warburton and Bredin,2 for each identified study, we will 
conduct graphical dose–response analyses of mortality 
as a function of activity-related energy consumption. 
The data regarding the dose of physical activity will be 
converted into a single unit (ie, MET hours/week). 
Only studies that investigate exposure to at least three 
different levels of physical activity will be included in the 
dose-response analysis. If the physical activity categories 
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are defined without assigning a specific value for energy 
expenditure, we will assume the corresponding absolute 
intensities to be 1.5–3.0 MET for a low level of physical 
activity; 3–6 MET for moderate physical activity; and 
≥6 MET for a high level of physical activity.30 31 When 
studies report the duration of different physical activities 
(eg, 30 min of walking, running or cycling), we will calcu-
late the energy expenditure based on the compendium of 
physical activities.30
Second, for each of the nine NCDs, summary RRs with 
95% CIs will be calculated when two or more studies of 
the same exposure and outcome are available. We will 
apply random effects meta-analysis, as described by DerSi-
monian and Laird.32 If a study reports on separate risk 
estimates for subgroups (eg, men and women), we will 
pool the data using a fixed-effect model and include the 
combined estimate in the overall meta-analysis.
Third, indication-specific linear dose-response 
meta-analyses will be conducted using the method 
described by Greenland and Longnecker.33 In addi-
tion, we will investigate the shape of the association by 
conducting non-linear dose-response meta-analysis, as 
described by Orsini et al.34 For this method, the following 
data for at least three exposure categories are required: 
(1) the quantified exposure value (MET hours/weeks); 
(2) the effect estimate with the corresponding 95% CI; 
and (3) the number of cases and person-years. If the 
information regarding the distribution of cases, person-
years or non-cases is missing, data will be estimated as 
previously described.35 36 The mean amount of exposure 
between two endpoints for each physical activity category 
will be calculated.2 When the lowest or highest category is 
open-ended (eg, <3), we will multiply the value by 1.25.4
Heterogeneity will be described by calculating Tau² 
to assess the between-study variance and calculating the 
I² statistic to investigate the variability of the observed 
effects in the meta-analyses.37 Possible sources of hetero-
geneity across the studies will be explored by conducting 
subgroup analyses and meta-regressions by accounting 
for various factors (eg, sex, age, geographic location of 
the studies, follow-up time, assessment of physical activity, 
risk of bias of the studies). The small-studies effect (eg, 
publication bias) will be investigated by conducting visual 
inspections of the funnel plots and applying Egger’s test, 
at which p<0.1 indicates potential publication bias.38 Data 
analyses will be performed using the statistical software 
Stata V.15. All tests will be two-sided, with statistical signif-
icance defined as p<0.05.
Patient and public involvement
As the systematic review will be based on published 
studies, patient or public involvement is not applicable.
Limitations
Some potential limitations are to be expected. First, 
prospective observational cohort studies fail to provide 
conclusive evidence of a causal relationship between 
physical activity and mortality.20 39–41 Consequently, our 
review of cohort studies does not provide a conclusive 
answer as to whether the reported relationships between 
physical activity and mortality are actually causal or only 
correlative. According to Hill,42 however, confidence in 
a causal relationship increases when (1) a clear dose-re-
sponse curve, (2) a strong association or a high effect 
size and (3) consistency of results in different studies 
are given. These three factors will be examined in our 
systematic review. Thus, this work can contribute to 
estimations of the likelihood of the causal influence of 
physical activity on mortality rates. Second, we will only 
include studies published in English. Studies published 
in other languages and grey, unpublished literature will 
not be included. Third, the wide range of tools available 
to measure physical activity in terms of their psycho-
metric properties and the domains that they assess may 
present another challenge. This variability in measure-
ment instruments may present difficulties in generating 
one single energy metric unit of physical activity, thus 
questioning the inclusion of all the eligible studies in 
the doseresponse analysis. However, we will consider 
any form of physical activity by representing it in associ-
ated energy consumption units, and we will not consider 
potential differences between different intensities (ie, 
light vs moderate vs vigorous) or between physical activity 
in different contexts (eg, leisure time physical activity vs 
occupational physical activity). Fourth, this study will only 
consider activity behaviour, not sedentary behaviour, even 
if there is a clear interaction between physical activity and 
sedentary behaviour with regard to mortality in healthy 
individuals.43
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